These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 8838439)

  • 1. Effect of ranitidine hydrochloride (150 mg twice daily) on the pharmacokinetics of increasing doses of ethanol (0.15, 0.3, 0.6 g kg-1).
    Bye A; Lacey LF; Gupta S; Powell JR
    Br J Clin Pharmacol; 1996 Feb; 41(2):129-33. PubMed ID: 8838439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ranitidine, cimetidine, famotidine have no effect on post-prandial absorption of ethanol 0.8 g/kg taken after an evening meal.
    Fraser AG; Hudson M; Sawyerr AM; Smith M; Rosalki SB; Pounder RE
    Aliment Pharmacol Ther; 1992 Dec; 6(6):693-700. PubMed ID: 1362497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ranitidine has no effect on postbreakfast ethanol absorption.
    Fraser AG; Hudson M; Sawyerr AM; Smith MS; Sercombe J; Rosalki SB; Pounder RE
    Am J Gastroenterol; 1993 Feb; 88(2):217-21. PubMed ID: 8424424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A pharmacokinetic and pharmacodynamic interaction study between nebivolol and the H2-receptor antagonists cimetidine and ranitidine.
    Kamali F; Howes A; Thomas SH; Ford GA; Snoeck E
    Br J Clin Pharmacol; 1997 Feb; 43(2):201-4. PubMed ID: 9131955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Omeprazole, ranitidine, and cimetidine have no effect on peak blood ethanol concentrations, first pass metabolism or area under the time-ethanol curve under 'real-life' drinking conditions.
    Brown AS; James OF
    Aliment Pharmacol Ther; 1998 Feb; 12(2):141-5. PubMed ID: 9692688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of effect of H2-receptor antagonists on the pharmacokinetics of alcohol consumed after food at lunchtime.
    Kendall MJ; Spannuth F; Walt RP; Gibson GJ; Hale KA; Braithwaite R; Langman MJ
    Br J Clin Pharmacol; 1994 Apr; 37(4):371-4. PubMed ID: 8018458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alcohol levels are increased in social drinkers receiving ranitidine.
    Arora S; Baraona E; Lieber CS
    Am J Gastroenterol; 2000 Jan; 95(1):208-13. PubMed ID: 10638585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short report: the effect of ranitidine on the post-prandial absorption of a low dose of alcohol.
    Fraser AG; Hudson M; Sawyerr AM; Rosalki SB; Pounder RE
    Aliment Pharmacol Ther; 1992 Apr; 6(2):267-71. PubMed ID: 1600045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ranitidine increases the bioavailability of postprandial ethanol by the reduction of first pass metabolism.
    Brown AS; Fiaterone JR; Day CP; Bennett MK; Kelly PJ; James OF
    Gut; 1995 Sep; 37(3):413-7. PubMed ID: 7590440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of food and ranitidine on saquinavir pharmacokinetics and gastric pH in healthy volunteers.
    Kakuda TN; Falcon RW
    Pharmacotherapy; 2006 Aug; 26(8):1060-8. PubMed ID: 16863482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative trial in volunteers to investigate possible ethanol-ranitidine interaction.
    Kleine MW; Ertl D
    Ann Pharmacother; 1993; 27(7-8):841-5. PubMed ID: 8364260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The inhibition of first-pass metabolism of ethanol by H
    Moody DE
    Expert Opin Drug Saf; 2018 Sep; 17(9):917-934. PubMed ID: 30117350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cimetidine and ranitidine. Lack of effect on the pharmacokinetics of an acute ethanol dose.
    Dauncey H; Chesher GB; Palmer RH
    J Clin Gastroenterol; 1993 Oct; 17(3):189-94. PubMed ID: 8228077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pretreatment with ranitidine does not reduce the bioavailability of orally administered topotecan.
    Akhtar S; Beckman RA; Mould DR; Doyle E; Fields SZ; Wright J
    Cancer Chemother Pharmacol; 2000; 46(3):204-10. PubMed ID: 11021737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [H2-receptor antagonists and alcohol: clinical significance].
    Nemesánszky E; Csepregi A
    Orv Hetil; 1996 Jun; 137(24):1309-13. PubMed ID: 8757090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the influence of antacids and H2 antagonists on the absorption of moxifloxacin after oral administration of a 400mg dose to healthy volunteers.
    Stass H; Böttcher MF; Ochmann K
    Clin Pharmacokinet; 2001; 40 Suppl 1():39-48. PubMed ID: 11352441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A pharmacokinetic interaction study between omeprazole and the H2-receptor antagonist ranitidine.
    Leucuta A; Vlase L; Farcau D; Nanulescu M
    Drug Metabol Drug Interact; 2004; 20(4):273-81. PubMed ID: 15663296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A lack of pharmacokinetic interaction between ranitidine and piroxicam.
    Dixon JS; Lacey LF; Pickup ME; Langley SJ; Page MC
    Eur J Clin Pharmacol; 1990; 39(6):583-6. PubMed ID: 1982764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of gastric alcohol dehydrogenase activity by histamine H2-receptor antagonists has no influence on the pharmacokinetics of ethanol after a moderate dose.
    Mallat A; Roudot-Thoraval F; Bergmann JF; Trout H; Simonneau G; Dutreuil C; Blanc LE; Dhumeaux D; Delchier JC
    Br J Clin Pharmacol; 1994 Feb; 37(2):208-11. PubMed ID: 7910473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. H2-antagonists and alcohol. Do they interact?
    Gugler R
    Drug Saf; 1994 Apr; 10(4):271-80. PubMed ID: 7912509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.